Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation

Background: Protease-activated receptor 1 (PAR1) and toll-like receptors (TLRs) are inflammatory mediators contributing to atherogenesis and atherothrombosis. Vorapaxar, which selectively antagonizes PAR1-signaling, is an approved, add-on antiplatelet therapy for secondary prevention. The non-hemost...

Descripción completa

Detalles Bibliográficos
Autores principales: Friebel, Julian, Moritz, Eileen, Witkowski, Marco, Jakobs, Kai, Strässler, Elisabeth, Dörner, Andrea, Steffens, Daniel, Puccini, Marianna, Lammel, Stella, Glauben, Rainer, Nowak, Franziska, Kränkel, Nicolle, Haghikia, Arash, Moos, Verena, Schutheiss, Heinz-Peter, Felix, Stephan B., Landmesser, Ulf, Rauch, Bernhard H., Rauch, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700178/
https://www.ncbi.nlm.nih.gov/pubmed/34944024
http://dx.doi.org/10.3390/cells10123517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700178/
https://www.ncbi.nlm.nih.gov/pubmed/34944024
http://dx.doi.org/10.3390/cells10123517

Ejemplares similares